MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • News
  • Store
  • Brokers
  • Download
  • Economic Calendar
  • Trading Signals
  • WebTerminal
  • Heatmap
  • Русский
  • 中文
  • Español
  • Português
  • 日本語
  • Deutsch
  • 한국어
  • Français
  • Italiano
  • Türkçe
Castle Biosciences, Inc. Common Stock

CSTL

#2734
Castle Biosciences, Inc. - Common stock
22.0 5 USD
-0.27%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
21.87
22.06
Year Range
0.20
44.28
Daily Change
-0.27%
Monthly Change
-10.00%
6 month change
-44.54%
Year Change
-10.42%
Previous Close
22.1 1
Open
21.9 9
Low
21.8 7
High
22.0 6
Volume
47
  1. Markets
  2. US Stock Market
  3. Healthcare
  4. CSTL
Open full chart Full chart

Financials

Overview Statement Statistics
Quarterly Annual
  • Market Capitalization 668.78 M
  • Employee 942
  • Founded 2007
  • CEO N/A
  • Website www.castlebiosciences.com
  • Headquarter Delaware, United States
  • FIGI BBG006YWVSR3
  • Industry Diagnostics & Research
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-46.87
Price to sales ratio
3.28

News

Zacks Zacks
CSTL AGEN
2026.05.06
Castle Biosciences, Inc. (CSTL) Reports Q1 Loss, Beats Revenue Estimates
Zacks Zacks
ALKS AGEN AMRN CSTL
2026.05.06
Alkermes' Q1 Earnings & Revenues Beat Estimates, Stock Rises
Zacks Zacks
CPRX CSTL OCGN INDV
2026.05.06
OCGN Falls on Wider Q1 Loss Despite Strong Pipeline Progress Outlook
Zacks Zacks
CPRX EDIT CSTL INDV
2026.05.06
EDIT's Q1 Loss Narrower Than Expected, Pipeline in Focus
Zacks Zacks
RGEN AGEN AMRN CSTL
2026.05.06
Repligen's Q1 Earnings & Revenues Beat Estimates, Stock Rises
Zacks Zacks
JAZZ CPRX CSTL
2026.05.06
JAZZ Stock Jumps as Q1 Earnings & Sales Surpass Expectations
Zacks Zacks
SNY BMRN CPRX CSTL
2026.05.05
BioMarin Q1 Earnings Miss, Sales Beat, '26 Revenue Guidance Raised
Zacks Zacks
CPRX KRYS CSTL INDV
2026.05.05
Krystal Biotech Q1 Earnings & Sales Beat Estimates, Pipeline in Focus
Zacks Zacks
JAZZ AXSM CSTL INDV
2026.05.05
AXSM Q1 Loss Widens, Revenues Jump on Higher Auvelity Sales
Zacks Zacks
CSTL
2026.05.05
Wall Street Analysts Predict an 85.15% Upside in Castle Biosciences (CSTL): Here's What You Should Know
Zacks Zacks
VRTX CPRX CRSP CSTL
2026.05.05
CRISPR Therapeutics' Q1 Loss Wider Than Expected, Sales Miss Estimates
Zacks Zacks
GSK MRK SMMT CSTL
2026.05.04
SMMT Q1 Loss Narrower Than Expected, Stock Down on Ivonescimab Setback

Markets

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Charts & Ideas

  • Trading Ideas
  • Education Ideas
  • Charts

MQL5 Community

  • Store
  • Signals
  • Forum
  • Articles
  • CodeBase

News

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Brokers

  • All Brokers
  • Forex
  • Stock
  • Metals
MetaTrader 5
Scan to install from App Store Scan to install from Google Play Scan to install from Huawei AppGallery Scan to install APK
MQL5 Channels
Scan to install from App Store Scan to install from Google Play Scan to install from Huawei AppGallery Scan to install APK
Economic Calendar
Scan to install from App Store Scan to install from Google Play Scan to install from Huawei AppGallery Scan to install APK
Risk Disclosure Terms of Use Help Contacts and Requests Legal
Copyright 2000-2026, MetaQuotes Ltd